"St. Petersburg General Hospital is now HCA Florida St. Petersburg Hospital. We provide comprehensive emergency, diagnostic, medical and surgical services. We are a Blue Distinction Center for Maternity Care, as designated by Blue Cross Blue Shield, and we offer advanced labor and delivery, postpartum and nursery services. Our hospital's mammography and ultrasound services are accredited by the American College of Radiology, and The Joint Commission designated our hospital as a Primary Stroke Center. We are also a Comprehensive Community Cancer Program. Other health services include GYN Robotic Surgery Training Epicenter, The Pelvic Pain and Incontinence Center and The Orthopedic Center. Visit our website to learn more."

During the past decade, OrKli Hospital LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OrKli Hospital LLC" #1 sponsor was "Ivix LLX" with 2 trials, followed by "Promomed, LLC" with 2 trials sponsored, "Valenta Pharm JSC" with 2 trials sponsored, "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OrKli Hospital LLC" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Sponsor GmbH" with 1 trials as a collaborator, "Synergy Research Inc." with 1 trials as a collaborator and "Zak-Pharma Dienstleistung Ges.m.b.H." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "OrKli Hospital LLC" are "Acute Respiratory Infection" (2 trials), "COVID-19" (2 trials), "Common Cold" (2 trials), "Influenza, Human" (2 trials) and "Acute Sore Throat" (1 trials). Many other conditions were trialed in "OrKli Hospital LLC" in a lesser frequency.

Most popular intervention types in "OrKli Hospital LLC" are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BP101" (2 trials), "Standard of care" (2 trials), "0.3% benzydamine hydrochloride spray oromucosal solution" (1 trials) and "Bacillus Calmette-Guerin" (1 trials). Other intervention names were less common.

The vast majority of trials in "OrKli Hospital LLC" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "OrKli Hospital LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in OrKli Hospital LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in OrKli Hospital LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".